摘要
Ropinirole is a modern, non ergoline dopamine agonist which has been shown to be effective as monotherapy as well as combination therapy against idiopathic P arkinsons disease. In addition to improving bradykinesia, rigor and tremor, it will amel iorate the abilities of daily living as well as depressive mood. The long term complications of L dopa are diminished and the existing complications are reduc ed. A neuroprotective effect is under discussion. In addition to Parkinsons di sease, ropinirole is also used successfully in the treatment of restless legs sy ndrome.
Ropinirole is a modern, non ergoline dopamine agonist which has been shown to be effective as monotherapy as well as combination therapy against idiopathic P arkinsons disease. In addition to improving bradykinesia, rigor and tremor, it will amel iorate the abilities of daily living as well as depressive mood. The long term complications of L dopa are diminished and the existing complications are reduc ed. A neuroprotective effect is under discussion. In addition to Parkinsons di sease, ropinirole is also used successfully in the treatment of restless legs sy ndrome.
出处
《世界核心医学期刊文摘（神经病学分册）》
2005年第3期45-46,共2页
Digest of the World Core Medical Journals:Clinical Neurology
